Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor

A. Enshaei; C. J. Schwab; Z. J. Konn; C. D. Mitchell; S. E. Kinsey; R. Wade; A. Vora; C. J. Harrison; A. V. Moorman

doi:10.1038/leu.2013.136

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor

A. Enshaei, C. J. Schwab, Z. J. Konn, C. D. Mitchell, S. E. Kinsey, R. Wade, A. Vora, C. J. Harrison, A. V. Moorman

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2256-2259
Number of pages	4
Journal	Leukemia
Volume	27
Issue number	11
DOIs	https://doi.org/10.1038/leu.2013.136
State	Published - Nov 2013
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2013.136

Cite this

@article{6ebea0447259426e9ce02a3393dafb2f,

title = "Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor",

author = "A. Enshaei and Schwab, {C. J.} and Konn, {Z. J.} and Mitchell, {C. D.} and Kinsey, {S. E.} and R. Wade and A. Vora and Harrison, {C. J.} and Moorman, {A. V.}",

note = "Funding Information: We thank (1) Leukaemia and Lymphoma Research (formerly Leukaemia Research, UK) for financial support; (2) member laboratories of the UK Cancer Cytogenetic Group for providing cytogenetic data and material; (3) past and present members of the Leukaemia Research Cytogenetics Group for their contribution in establishing this data set; in particular, Halima Al-Shehhi, Kerry E Barber, Lucy Chilton, Amy Erhorn, Lisa Jones, Heather Morrison and Sarah Wright. Primary childhood leukaemia samples used in this study were provided by the Leukaemia and Lymphoma Research Childhood Leukaemia Cell Bank working with the laboratory teams in the Bristol Genetics Laboratory, Southmead Hospital, Bristol; Molecular Biology Laboratory, Royal Hospital for Sick Children, Glasgow; Molecular Haematology Laboratory, Royal London Hospital, London; and Molecular Genetics Service and Sheffield Children{\textquoteright}s Hospital, Sheffield.",

year = "2013",

month = nov,

doi = "10.1038/leu.2013.136",

language = "English (US)",

volume = "27",

pages = "2256--2259",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor

AU - Enshaei, A.

AU - Schwab, C. J.

AU - Konn, Z. J.

AU - Mitchell, C. D.

AU - Kinsey, S. E.

AU - Wade, R.

AU - Vora, A.

AU - Harrison, C. J.

AU - Moorman, A. V.

N1 - Funding Information: We thank (1) Leukaemia and Lymphoma Research (formerly Leukaemia Research, UK) for financial support; (2) member laboratories of the UK Cancer Cytogenetic Group for providing cytogenetic data and material; (3) past and present members of the Leukaemia Research Cytogenetics Group for their contribution in establishing this data set; in particular, Halima Al-Shehhi, Kerry E Barber, Lucy Chilton, Amy Erhorn, Lisa Jones, Heather Morrison and Sarah Wright. Primary childhood leukaemia samples used in this study were provided by the Leukaemia and Lymphoma Research Childhood Leukaemia Cell Bank working with the laboratory teams in the Bristol Genetics Laboratory, Southmead Hospital, Bristol; Molecular Biology Laboratory, Royal Hospital for Sick Children, Glasgow; Molecular Haematology Laboratory, Royal London Hospital, London; and Molecular Genetics Service and Sheffield Children’s Hospital, Sheffield.

PY - 2013/11

Y1 - 2013/11

UR - http://www.scopus.com/inward/record.url?scp=84887318371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887318371&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.136

DO - 10.1038/leu.2013.136

M3 - Letter

C2 - 23636228

AN - SCOPUS:84887318371

SN - 0887-6924

VL - 27

SP - 2256

EP - 2259

JO - Leukemia

JF - Leukemia

IS - 11

ER -

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this